联合疗法-话题@MedSci

#联合疗法#

64篇内容 | 2311人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1646972, encodeId=aaca16469e29d, content=<a href='/topic/show?id=0eb280e174e' target=_blank style='color:#2F92EE;'>#联合疗法#</a>, objectTitle=INFECT DIS P：在急性疟疾患儿中采用青蒿素为基础的联合疗法一天后寄生虫减少率及其与寄生虫清除时间的关系, objectType=article, longId=159304, objectId=43a1159304fc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=43a1159304fc, replyNumber=0, likeNumber=59, createdTime=2019-02-17, rootId=0, userName=wincls, userId=2fce23370592, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=43a1159304fc, moduleTitle=INFECT DIS P：在急性疟疾患儿中采用青蒿素为基础的联合疗法一天后寄生虫减少率及其与寄生虫清除时间的关系, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=43a1159304fc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1646978, encodeId=46a016469e855, content=<a href='/topic/show?id=0eb280e174e' target=_blank style='color:#2F92EE;'>#联合疗法#</a>, objectTitle=Sci Trans Med：新联合疗法截断肿瘤免疫逃逸之路, objectType=article, longId=179858, objectId=3df41e985844, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3df41e985844, replyNumber=0, likeNumber=54, createdTime=2019-12-05, rootId=0, userName=wincls, userId=2fce23370592, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3df41e985844, moduleTitle=Sci Trans Med：新联合疗法截断肿瘤免疫逃逸之路, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3df41e985844)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1646977, encodeId=ec5b16469e749, content=<a href='/topic/show?id=0eb280e174e' target=_blank style='color:#2F92EE;'>#联合疗法#</a>, objectTitle=Eur Urol：转移肾细胞癌的一线肿瘤免疫联合疗法疗效分析, objectType=article, longId=178622, objectId=10781e8622b5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=10781e8622b5, replyNumber=0, likeNumber=64, createdTime=2020-08-02, rootId=0, userName=wincls, userId=2fce23370592, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=10781e8622b5, moduleTitle=Eur Urol：转移肾细胞癌的一线肿瘤免疫联合疗法疗效分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=10781e8622b5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1646970, encodeId=890616469e094, content=<a href='/topic/show?id=0eb280e174e' target=_blank style='color:#2F92EE;'>#联合疗法#</a>, objectTitle=CHMP：Kisqali联合疗法扩展至所有HR + / HER2-局部晚期或转移性乳腺癌的女性, objectType=article, longId=153910, objectId=a18915391059, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a18915391059, replyNumber=0, likeNumber=76, createdTime=2019-05-03, rootId=0, userName=wincls, userId=2fce23370592, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a18915391059, moduleTitle=CHMP：Kisqali联合疗法扩展至所有HR + / HER2-局部晚期或转移性乳腺癌的女性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a18915391059)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1646973, encodeId=74d516469e373, content=<a href='/topic/show?id=0eb280e174e' target=_blank style='color:#2F92EE;'>#联合疗法#</a>, objectTitle=PNAS：科学家找到“癌中之王”胰腺癌的潜在联合疗法, objectType=article, longId=163175, objectId=89eb1631e59a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=89eb1631e59a, replyNumber=0, likeNumber=64, createdTime=2019-08-26, rootId=0, userName=wincls, userId=2fce23370592, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=89eb1631e59a, moduleTitle=PNAS：科学家找到“癌中之王”胰腺癌的潜在联合疗法, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=89eb1631e59a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1646969, encodeId=cdfc164696949, content=<a href='/topic/show?id=0eb280e174e' target=_blank style='color:#2F92EE;'>#联合疗法#</a>, objectTitle=降低 50% 进展风险，联合疗法获批治疗血液癌症, objectType=article, longId=137641, objectId=e3ba13e641a1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e3ba13e641a1, replyNumber=0, likeNumber=50, createdTime=2018-08-20, rootId=0, userName=wincls, userId=2fce23370592, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e3ba13e641a1, moduleTitle=降低 50% 进展风险，联合疗法获批治疗血液癌症, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e3ba13e641a1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1646971, encodeId=e07a16469e1cf, content=<a href='/topic/show?id=0eb280e174e' target=_blank style='color:#2F92EE;'>#联合疗法#</a>, objectTitle=Ann Pharmacother：产碳青霉烯酶肺炎克雷伯菌感染患者：双碳青霉烯联合疗法是否安全有效？, objectType=article, longId=157468, objectId=098a15e468e6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=098a15e468e6, replyNumber=0, likeNumber=68, createdTime=2019-04-14, rootId=0, userName=wincls, userId=2fce23370592, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=098a15e468e6, moduleTitle=Ann Pharmacother：产碳青霉烯酶肺炎克雷伯菌感染患者：双碳青霉烯联合疗法是否安全有效？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=098a15e468e6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1646967, encodeId=3ca1164696e61, content=<a href='/topic/show?id=0eb280e174e' target=_blank style='color:#2F92EE;'>#联合疗法#</a>, objectTitle=PD-1联合疗法“大战”开启, objectType=article, longId=126937, objectId=c34112693ea3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c34112693ea3, replyNumber=0, likeNumber=73, createdTime=2018-05-09, rootId=0, userName=wincls, userId=2fce23370592, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c34112693ea3, moduleTitle=PD-1联合疗法“大战”开启, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c34112693ea3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1646966, encodeId=c2c41646966d1, content=<a href='/topic/show?id=0eb280e174e' target=_blank style='color:#2F92EE;'>#联合疗法#</a>, objectTitle=Lancet infect dis：对于流感，奥司他韦、金刚烷胺和利巴韦林联合疗法竟不比奥司他韦单一疗法的效果好！, objectType=article, longId=113927, objectId=636511392e4b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=636511392e4b, replyNumber=0, likeNumber=99, createdTime=2017-11-03, rootId=0, userName=wincls, userId=2fce23370592, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=636511392e4b, moduleTitle=Lancet infect dis：对于流感，奥司他韦、金刚烷胺和利巴韦林联合疗法竟不比奥司他韦单一疗法的效果好！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=636511392e4b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1646964, encodeId=812316469647a, content=<a href='/topic/show?id=0eb280e174e' target=_blank style='color:#2F92EE;'>#联合疗法#</a>, objectTitle=Aliment Pharm Ther：接受联合疗法的炎性肠炎患者：硫唑嘌呤减量有效吗？, objectType=article, longId=111684, objectId=f1cb111684bf, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f1cb111684bf, replyNumber=0, likeNumber=61, createdTime=2018-08-15, rootId=0, userName=wincls, userId=2fce23370592, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f1cb111684bf, moduleTitle=Aliment Pharm Ther：接受联合疗法的炎性肠炎患者：硫唑嘌呤减量有效吗？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f1cb111684bf)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1646968, encodeId=bfa81646968e7, content=<a href='/topic/show?id=0eb280e174e' target=_blank style='color:#2F92EE;'>#联合疗法#</a>, objectTitle=一种新的联合疗法给癌症前所未有的致命抗击！, objectType=article, longId=133633, objectId=e5d6133633b4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e5d6133633b4, replyNumber=0, likeNumber=69, createdTime=2019-02-06, rootId=0, userName=wincls, userId=2fce23370592, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e5d6133633b4, moduleTitle=一种新的联合疗法给癌症前所未有的致命抗击！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e5d6133633b4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1646965, encodeId=c0d61646965c3, content=<a href='/topic/show?id=0eb280e174e' target=_blank style='color:#2F92EE;'>#联合疗法#</a>, objectTitle=重要警示！2篇论文证实：这种PD-1抗体联合疗法，效果不佳还“有害”, objectType=article, longId=112124, objectId=d7d011212479, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d7d011212479, replyNumber=0, likeNumber=48, createdTime=2017-11-19, rootId=0, userName=wincls, userId=2fce23370592, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d7d011212479, moduleTitle=重要警示！2篇论文证实：这种PD-1抗体联合疗法，效果不佳还“有害”, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d7d011212479)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1646963, encodeId=825116469631a, content=<a href='/topic/show?id=0eb280e174e' target=_blank style='color:#2F92EE;'>#联合疗法#</a>, objectTitle=纳米药物联合疗法增强癌症免疫疗法疗效！, objectType=article, longId=96277, objectId=c8ee962e7c8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c8ee962e7c8, replyNumber=0, likeNumber=85, createdTime=2017-06-11, rootId=0, userName=wincls, userId=2fce23370592, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c8ee962e7c8, moduleTitle=纳米药物联合疗法增强癌症免疫疗法疗效！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c8ee962e7c8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1646960, encodeId=bc8e1646960f7, content=<a href='/topic/show?id=0eb280e174e' target=_blank style='color:#2F92EE;'>#联合疗法#</a>, objectTitle=NEJM：PD-1联合疗法导致2名患者死亡，原因是心脏风险！, objectType=article, longId=81782, objectId=781181e8295, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=781181e8295, replyNumber=0, likeNumber=63, createdTime=2017-02-25, rootId=0, userName=wincls, userId=2fce23370592, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=781181e8295, moduleTitle=NEJM：PD-1联合疗法导致2名患者死亡，原因是心脏风险！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=781181e8295)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1646962, encodeId=1df8164696290, content=<a href='/topic/show?id=0eb280e174e' target=_blank style='color:#2F92EE;'>#联合疗法#</a>, objectTitle=Nat Rev Cancer：深度好文—癌症免疫联合疗法如何做？这里或许有答案！, objectType=article, longId=94830, objectId=3155948309c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3155948309c, replyNumber=0, likeNumber=48, createdTime=2017-04-20, rootId=0, userName=wincls, userId=2fce23370592, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3155948309c, moduleTitle=Nat Rev Cancer：深度好文—癌症免疫联合疗法如何做？这里或许有答案！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3155948309c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1646961, encodeId=b9b1164696129, content=<a href='/topic/show?id=0eb280e174e' target=_blank style='color:#2F92EE;'>#联合疗法#</a>, objectTitle=1/4剂量四药联合疗法可作为高血压初始治疗方案, objectType=article, longId=90150, objectId=44329015031, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=44329015031, replyNumber=0, likeNumber=85, createdTime=2017-11-12, rootId=0, userName=wincls, userId=2fce23370592, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=44329015031, moduleTitle=1/4剂量四药联合疗法可作为高血压初始治疗方案, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=44329015031)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1646959, encodeId=79b91646959ad, content=<a href='/topic/show?id=0eb280e174e' target=_blank style='color:#2F92EE;'>#联合疗法#</a>, objectTitle=Nat Med：联合疗法或可有效抵御胰腺癌, objectType=article, longId=72192, objectId=9413e219289, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9413e219289, replyNumber=0, likeNumber=81, createdTime=2016-08-29, rootId=0, userName=wincls, userId=2fce23370592, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9413e219289, moduleTitle=Nat Med：联合疗法或可有效抵御胰腺癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9413e219289)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1646958, encodeId=85f816469584c, content=<a href='/topic/show?id=0eb280e174e' target=_blank style='color:#2F92EE;'>#联合疗法#</a>, objectTitle=Lancet Respir Med：联合疗法vs.单一疗法治疗肺动脉高压的临床疗效, objectType=article, longId=63907, objectId=26806390e36, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=26806390e36, replyNumber=0, likeNumber=54, createdTime=2016-07-19, rootId=0, userName=wincls, userId=2fce23370592, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=26806390e36, moduleTitle=Lancet Respir Med：联合疗法vs.单一疗法治疗肺动脉高压的临床疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=26806390e36)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1646957, encodeId=2aa3164695e66, content=<a href='/topic/show?id=0eb280e174e' target=_blank style='color:#2F92EE;'>#联合疗法#</a>, objectTitle=Cancer Res：新型药物联合疗法治疗胰腺癌, objectType=article, longId=51650, objectId=dd6f516506e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dd6f516506e, replyNumber=0, likeNumber=66, createdTime=2015-10-18, rootId=0, userName=wincls, userId=2fce23370592, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dd6f516506e, moduleTitle=Cancer Res：新型药物联合疗法治疗胰腺癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dd6f516506e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1646956, encodeId=ccaa1646956d4, content=<a href='/topic/show?id=0eb280e174e' target=_blank style='color:#2F92EE;'>#联合疗法#</a>, objectTitle=Oncotarget：胶质母细胞瘤新联合疗法, objectType=article, longId=50596, objectId=a85c50596d1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a85c50596d1, replyNumber=0, likeNumber=69, createdTime=2016-02-07, rootId=0, userName=wincls, userId=2fce23370592, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a85c50596d1, moduleTitle=Oncotarget：胶质母细胞瘤新联合疗法, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a85c50596d1)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

联合疗法

2020-05-29

wincls (审核中...)

前往app查看评论内容

#联合疗法#

INFECT DIS P：在急性疟疾患儿中采用青蒿素为基础的联合疗法一天后寄生虫减少率及其与寄生虫清除时间的关系

2019-02-17

wincls (审核中...)

前往app查看评论内容

#联合疗法#

Sci Trans Med：新联合疗法截断肿瘤免疫逃逸之路

2019-12-05

wincls (审核中...)

前往app查看评论内容

#联合疗法#

Eur Urol：转移肾细胞癌的一线肿瘤免疫联合疗法疗效分析

2020-08-02

wincls (审核中...)

前往app查看评论内容

#联合疗法#

CHMP：Kisqali联合疗法扩展至所有HR + / HER2-局部晚期或转移性乳腺癌的女性

2019-05-03

wincls (审核中...)

前往app查看评论内容

#联合疗法#

PNAS：科学家找到“癌中之王”胰腺癌的潜在联合疗法

2019-08-26

wincls (审核中...)

前往app查看评论内容

#联合疗法#

降低 50% 进展风险，联合疗法获批治疗血液癌症

2018-08-20

wincls (审核中...)

前往app查看评论内容

#联合疗法#

Ann Pharmacother：产碳青霉烯酶肺炎克雷伯菌感染患者：双碳青霉烯联合疗法是否安全有效？

2019-04-14

wincls (审核中...)

前往app查看评论内容

#联合疗法#

PD-1联合疗法“大战”开启

2018-05-09

wincls (审核中...)

前往app查看评论内容

#联合疗法#

Lancet infect dis：对于流感，奥司他韦、金刚烷胺和利巴韦林联合疗法竟不比奥司他韦单一疗法的效果好！

2017-11-03

wincls (审核中...)

前往app查看评论内容

#联合疗法#

Aliment Pharm Ther：接受联合疗法的炎性肠炎患者：硫唑嘌呤减量有效吗？

2018-08-15

wincls (审核中...)

前往app查看评论内容

#联合疗法#

一种新的联合疗法给癌症前所未有的致命抗击！

2019-02-06

wincls (审核中...)

前往app查看评论内容

#联合疗法#

重要警示！2篇论文证实：这种PD-1抗体联合疗法，效果不佳还“有害”

2017-11-19

wincls (审核中...)

前往app查看评论内容

#联合疗法#

纳米药物联合疗法增强癌症免疫疗法疗效！

2017-06-11

wincls (审核中...)

前往app查看评论内容

#联合疗法#

NEJM：PD-1联合疗法导致2名患者死亡，原因是心脏风险！

2017-02-25

wincls (审核中...)

前往app查看评论内容

#联合疗法#

Nat Rev Cancer：深度好文—癌症免疫联合疗法如何做？这里或许有答案！

2017-04-20

wincls (审核中...)

前往app查看评论内容

#联合疗法#

1/4剂量四药联合疗法可作为高血压初始治疗方案

2017-11-12

wincls (审核中...)

前往app查看评论内容

#联合疗法#

Nat Med：联合疗法或可有效抵御胰腺癌

2016-08-29

wincls (审核中...)

前往app查看评论内容

#联合疗法#

Lancet Respir Med：联合疗法vs.单一疗法治疗肺动脉高压的临床疗效

2016-07-19

wincls (审核中...)

前往app查看评论内容

#联合疗法#

Cancer Res：新型药物联合疗法治疗胰腺癌

2015-10-18

wincls (审核中...)

前往app查看评论内容

#联合疗法#

Oncotarget：胶质母细胞瘤新联合疗法

2016-02-07

科室
- - 订阅+
  - 更多科室
工具
服务